CRO News Evestia Clinical Acquires Belgian Medical Writing Specialist Emtex Life Science to Expand European CRO Presence 4 November 2026
CRO News AKEURA Launches as Specialist CRO Combining Clinical Development and Real-World Evidence After P95 and Julius Clinical Integration 3 November 2026
CRO News PSI CRO Partners with Appian to Deploy AI-Powered Clinical Trial Site Selection Platform 29 October 2026
CRO News ProtaGene Appoints Former Merck KGaA CDMO Executive Matthias Bucerius as CEO 29 October 2026
CRO News Transpharmation Acquires OrganoTherapeutics to Combine Translational In Vivo CRO Expertise With Human Stem Cell-Derived Organoid Technology 29 October 2026
CRO News LGM Pharma Acquires Sannova Analytical to Expand GLP Bioanalytical and cGMP Testing Services 26 October 2026
CRO News Fortrea and Omico Collaborate to Connect Genomically Profiled Patients With Biomarker-Led CRO Oncology Trials in Australia 23 October 2026
CRO News Marvel Biosciences Signs LOI With Novotech CRO for Phase 1 First-in-Human Trial of MB-204 in Australia 8 October 2026
CRO News Quantum BioPharma Signs Phase 2 Study Start-Up Agreement With Thermo Fisher’s PPD CRO for First-in-Class MS Candidate Lucid-MS 7 October 2026
CRO News CellCarta and Imagene AI Expand CRO Collaboration to Validate and Deploy AI-Powered Biomarker and CDx Programs With Leading Pharma Partners 2 October 2026
